tm logo
MELIUS
SEARCHED

on 06 Aug 2024

Last Applicant/ Owned by

MELIUS MICROBIOMICS INC.

1050-1040 Georgia St WVancouver

BRITISH COLUMBIA

CA

V6E4H1

Serial Number

2276339 filed on 18th Aug 2023

Correspondent Address

704 - 1478 Hastings St. WestVancouver

BRITISH COLUMBIA

CA

V6G3J6

MELIUS

Trademark usage description

administering medication reimbursement programs and services; administration and management of research grants; administration of prescription drug pr Read More

Classification Information


Class [005]
Pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for the treatment of digestive diseases and disorders, namely, crohn's disease, irritable bowel syndrome; probiotic bacterial formulations for medical purposes; probiotic preparations for medical purposes to help maintain a natural balance of flora in the digestive system


Classification kind code

12

Class [035]
Administering medication reimbursement programs and services; administration and management of research grants; administration of prescription drug programs designed to process medical insurance claims for products used by consumers; administration of prescription drug programs designed to process medical insurance claims for services used by consumers; administrative services for medical referrals; advertising services for promoting public awareness of the benefits of general health and wellness; advertising services for promoting public awareness of the benefits of nutrition; advertising services to promote public awareness of medical conditions; advertising services to promote public awareness on health issues; advertising services to promote public awareness on healthcare issues; analysis of market research data and statistics; assisting others in preparing and filing applications for new drugs with governmental regulatory bodies; business administration of a program to provide access to medicines at low or no cost to underserved populations; business administration of a program to provide discounts on prescription medicines; business administration of medication reimbursement programs and services; business mediation in the purchase and sale of health preparations for medical purposes; collection of medical reports; compilation of medical reports; compilation of statistical data for use in scientific or medical research; consulting services in the field of administrative processing of health insurance claims for health insurers, administrators and payers; consulting services in the field of medical product approval for commercial purposes; consulting services in the field of patient relationship management for healthcare providers; market analysis; market analysis and research; market assessment consultancy; market assessment services; market reports and studies; market research consultancy; market research services; market research studies; market studies; medical billing; medical billing support services; medical cost management; medical records coding services for others for purposes of reimbursement from insurance; medical referrals; on-line retail store services featuring dietary supplements; on-line retail store services featuring dietetic preparations; on-line wholesale store services featuring dietary supplements; on-line wholesale store services featuring dietetic preparations; online and retail sale of prescription drugs


Classification kind code

12

Class [039]
Delivery of prescription drugs


Classification kind code

12

Class [042]
Pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticals; research on the subject of pharmaceuticals


Classification kind code

12

Mark Details


Serial Number

2276339

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 22
on 06th Aug 2024
Search Recorded
Submitted for opposition 20
on 06th Aug 2024
Examiner's First Report
Submitted for opposition 30
on 18th Aug 2023
Filed
Submitted for opposition 1
on 18th Aug 2023
Created
Submitted for opposition 31
on 18th Aug 2023
Formalized